Table 3 Postoperative long-term complications and follow-up data.

Urethrostenosis (%)

6 (7.0)

11 (2.6)

4 (2.8)

0.105

Urethral stenosis requiring dilation only (CDS II, %)

4 (4.7)

8 (2.8)

3 (2.0)

0.487

Urethral stenosis requiring urethrotomy (CD S III, %)

2 (2.3)

3 (1.2)

1 (0.6)

0.066

Neurogenic bladder (CDS II, %)

5 (5.9)

25 (6.0)

6 (4.2)

0.439

UIND (< 1 month, CDS II, %)

12 (14.1)

28 (6.9)^a

6 (4.2)^b

0.030

Urge

3 (3.5)

7 (1.7)

2 (1.4)

Stress

7 (8.2)

12 (2.9)

3 (2.1)

Mixed

2 (2.4)

9 (2.2)

1 (0.7)

UIND (1-3 month, CDS II, %)

7 (8.2)

12 (2.9)^a

3 (2.1)^b

0.007

Urge

1 (1.2)

3 (0.7)

1 (0.7)

Stress

4 (4.7)

5 (1.2)

2 (1.4)

Mixed

2 (2.4)

4 (1.0)

0 (0.0)

UIND (3-12 month, CDS II, %)

5 (5.9)

6 (1.4)

1 (0.7)

0.041

Urge

1 (1.2)

1 (0.2)

1 (0.7)

Stress

3 (3.5)

3 (0.7)

0 (0.0)

Mixed

1 (1.2)

2 (0.5)

0 (0.0)

UIWND (< 1 month, CDS I, %)

14 (16.4)

34 (8.1)^a

9 (6.3)^b

0.023

Urge

2 (2.4)

5 (1.2)

1 (0.7)

Stress

7 (8.2)

21 (5.0)

5 (3.5)

Mixed

4 (4.7)

8 (1.9)

3 (2.1)

UIWND (1-3 month, CDS I, %)

6 (7.1)

10 (2.3)

3 (2.1)

0.171

Urge

0 (0.0)

1 (0.2)

0 (0.0)

Stress

3 (3.5)

6 (1.4)

2 (1.4)

Mixed

3 (3.5)

3 (0.7)

1 (0.7)

UIWND (3-12 month, CDS I, %)

1 (1.2)

4 (1.0)

0 (0.0)

0.477

Urge

0 (0.0)

0 (0.0)

0 (0.0)

Stress

1 (1.2)

3 (0.7)

0 (0.0)

Mixed

0 (0.0)

1 (0.2)

0 (0.0)

Bladder neck contracture (CDS III, %)

8 (9.4)

20 (4.8)

8 (5.7)

0.241

Time of bladder neck contracture after operation, m

8.00±2.54

9.64±4.40

9.25±1.71

0.460

PVR 3 months after surgery, ml

22.12±16.09

21.48±20.14

19.63±16.66

0.529

Decrease in PVR, ml

79.51±38.68

83.41±58.69

89.78±36.53

0.274

Qmax 3 months after surgery, mL/s

20.89±4.77

22.13±5.36^a

22.40±5.26^b

0.090

Increase in Qmax, mL/s

14.41±5.35

14.70±6.21

15.24±5.81

0.537

IPSS 3 months after surgery

7.67±3.15

6.33±3.20^a

6.11±3.16^b

0.001

QoL 3 months after surgery

1.36±1.05

1.40±1.09

1.29±0.82

0.550